Activity value 71china Supplier,Last transaction date:
2025-12-10
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for chongqing pharmedical limied from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 4 transactions, with a transaction quantity of 165.55 and a transaction weight of 0.
YearTransactionsQuantityWeight
2024000
20254165.550
Bill of lading data
<
1/4
>
Trade date
2025/12/10
B/L No.
——
Suppliers
chongqing pharmedical limied
Buyers
martin dow marker ltd.
POLs
——
PODs
kpfi
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
424.1
Hs code
29221990
Product tags
pharmaceutical raw material,fluoxetine
Product description
PHARMACEUTICAL RAW MATERIAL: FLUOXETINE HCL
Expand
chongqing pharmedical limied is china Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,asc,bat.
According to the 52wmb.com global trade database, as of 2025-12-10, the company has completed 4 international trades,
with its main trading regions covering pakistan etc.
The core products include HS29400000,HS29379000,HS29349990 etc,
and its main trading partners are swiss pharmaceuticals pvt ltd.,hilton pharmp pvt ltd.,sami pharmaceutical pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on chongqing pharmedical limied is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.